David Apelian

Insider Reports History

Entity
Individual
Location
C/O Achillion Pharmaceuticals, Inc, 300 George Street, New Haven, CT
Signature
/s/ David Apelian
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Apelian:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eiger BioPharmaceuticals, Inc. CEO, Director Stock Option (Right to Buy) 750K Jul 3, 2023 Direct

Insider Reports Filed by David Apelian

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EIGR Eiger BioPharmaceuticals, Inc. Jul 3, 2023 1 $0 4 Jul 6, 2023 CEO, Director
EIGR Eiger BioPharmaceuticals, Inc. Jan 31, 2023 1 $0 4 Feb 2, 2023 Interim CEO, Director
EIGR Eiger BioPharmaceuticals, Inc. Aug 16, 2022 1 -$49K 4 Aug 18, 2022 Director
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Director